Business
MedMira Names Robyn Cook as Chief Corporate Officer
HALIFAX , Nov. 4, 2014 /CNW/ - MedMira, Inc. (MedMira) (TSXV: MIR) announced today that ...

About this update from Medmira Inc.
[{"type":"text","content":"\n\nHALIFAX, Nov. 4, 2014 /CNW/ - MedMira, Inc. (MedMira) (TSXV: MIR) announced today that Robyn Cook has been appointed as the Company's Chief Corporate Officer, effective immediately.  Ms. Cook most recently served as MedMira's Senior Director of Corporate Governance.  She will continue in her role as the Company's Corporate Secretary. \n\nMs. Cook brings a wealth of experience to the position of Chief Corporate Officer, built on over 14 years working in a variety of progressively senior roles at MedMira, spanning corporate governance, compliance, operations, business process and policy development, and human resources.  As Chief Corporate Officer, Ms. Cook will focus on organizational alignment and prioritization of corporate strategy, implementation of industry best practices, and maximizing excellence across all MedMira business units\n\n\"Robyn has been a valued member of the Company's senior leadership team for many years, consistently delivering results.  The Board and management team look forward to Robyn's continued contributions to MedMira's growth and success in this new role,\" said Marvyn Robar, Chairman of the Board, MedMira Inc.  \"With hands-on experience and extensive knowledge of many of the key departments within our organization, Robyn is uniquely qualified to strategically connect and align the various parts of our business to drive performance and results.\" \n\nPrior to joining MedMira, Ms. Cook worked in the energy and education sectors.  She holds a Masters of Business Administration from Saint Mary's University, where the focus of her studies were corporate governance best practices in public life sciences companies.  Ms. Cook also holds a Masters of Science, Nova Scotia Agricultural College and a Bachelor of Science from Dalhousie University.\n\nMs. Cook's appointment as MedMira's Chief Corporate Officer is subject to final approval of the TSX Venture Exchange.\n\nAbout MedMira\n\nMedMira is a leading developer and manufacturer of vertical flow rapid diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and hepatitis C in just three easy steps. The Company's tests are sold under the Revealâ, Multiplo™ and Miriad™ brands in global markets. Based on its patented Rapid Vertica...